drugset / Trial / NCT00973076
Study to Assess the Safety and Tolerability of the Tor Kinase Inhibitor AZD8055
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The primary objective is to assess the safety and tolerability of AZD8055 in Japanese patients with advanced solid tumours.
Timeline
- Start
- 2009-08
- Primary completion
- 2010-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD8055 | Small molecule | 10 mg | Oral |
| Subject | AZD8055 | Small molecule | 40 mg | Oral |
| Subject | AZD8055 | Small molecule | 60 mg | Oral |
| Subject | AZD8055 | Small molecule | 90 mg | Oral |